EUVIMEDEUVIMED entdecken
Open Access

Fas Apoptosis Inhibitory Molecule 2 Inhibits Pathological Cardiac Hypertrophy by Regulating the MAPK Signaling Pathway

Huaping Zhong, Minyu Wu, Heping Xie, Xu Chen, Jiayi Li, Zhisheng Duan, Hong Chen, Ziyou Liu, Wei Liao iD, Yijian Chen iD

Journal of the American Heart Association · 2024

DOI: 10.1161/jaha.124.034257 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Huaping Zhong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Suzhou Medical College of Soochow University Suzhou China. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Mice, Knockout, Cardiomegaly, Phenylephrine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pathological cardiac hypertrophy stands as a pivotal mechanism contributing to diverse cardiovascular diseases, ultimately leading to heart failure. Despite its clinical significance, the intricate molecular mechanisms instigating pathological cardiac hypertrophy remain inadequately understood. In this study, we aim to further reveal its complex pathogenesis by exploring the role of Fas apoptotic inhibitory molecule 2 (FAIM2) in modulating pathological cardiac hypertrophy. Methods and Results We used phenylephrine‐induced hypertrophic cardiomyocytes and also generated cardiac‐specific knockout mice and adeno‐associated virus serotype 9‐Faim2 mice to evaluate the function of FAIM2 in pathological myocardial hypertrophy. Furthermore, unbiased RNA‐sequencing analysis was used to identify the direct target and corresponding molecular events contributing to FAIM2 function. Ultimately, our study revealed a downregulation of FAIM2 expression in phenylephrine‐induced hypertrophic cardiomyocytes and pressure overload–induced hypertrophic hearts. FAIM2 exhibited a significant attenuation of phenylephrine‐induced enlargement of primary neonatal rat cardiomyocytes, whereas FAIM2 knockdown aggravated the hypertrophic response. Furthermore, Faim2 gene knockout significantly exacerbated cardiac hypertrophy and heart fibrosis in vivo. Mechanistic investigations unveiled that FAIM2 exerts its inhibitory effect by suppressing TAK1‐JNK1/2‐p38 MAPK signaling cascades, thereby mitigating cardiac hypertrophy.

Conclusions

Our findings position FAIM2 as a novel negative regulator of pathological cardiac hypertrophy through its inhibitory action on mitogen‐activated protein kinase signaling activation. This identification of FAIM2's role provides crucial insights that may pave the way for the development of effective therapeutic strategies aimed at mitigating pathological cardiac hypertrophy, addressing a critical need in cardiovascular disease management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocytes, CardiacMice, KnockoutCardiomegalyPhenylephrineAnimalsMiceRatsMAP Kinase Signaling SystemDisease Models, AnimalMaleMice, Inbred C57BLApoptosis Regulatory ProteinsCells, CulturedRats, Sprague-DawleyFibrosis

Stichwörter der Autor:innen

FAIM2cardiac hypertrophyfibrosisheart failuretherapy

Substanzen

PhenylephrineApoptosis Regulatory Proteins

Autor:innen und Institutionen

  • Suzhou Medical College of Soochow University Suzhou China.
  • Heart Center The First Affiliated Hospital of Gannan Medical University Ganzhou China.
  • Gannan Innovation and Translational Medicine Research Institute Gannan Medical University Ganzhou China.
  • Wuhan Britain-China School Wuhan China.
  • Gannan Medical University Ganzhou China.
  • Department of Hematology The First Affiliated Hospital of Gannan Medical University Ganzhou China.

ORCID-Profile: Wei Liao, Yijian Chen

Zitieren

APA

Zhong, H., Wu, M., Xie, H., Chen, X., Li, J., Duan, Z., Chen, H., Liu, Z., Liao, W., & Chen, Y. (2024). Fas Apoptosis Inhibitory Molecule 2 Inhibits Pathological Cardiac Hypertrophy by Regulating the MAPK Signaling Pathway. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.034257

Vancouver

Zhong H, Wu M, Xie H, Chen X, Li J, Duan Z, et al. Fas Apoptosis Inhibitory Molecule 2 Inhibits Pathological Cardiac Hypertrophy by Regulating the MAPK Signaling Pathway. Journal of the American Heart Association. 2024. doi:10.1161/jaha.124.034257

BibTeX
@article{Zhong2024,
  author = {Zhong, Huaping and Wu, Minyu and Xie, Heping and Chen, Xu and Li, Jiayi and Duan, Zhisheng and Chen, Hong and Liu, Ziyou and Liao, Wei and Chen, Yijian},
  title = {Fas Apoptosis Inhibitory Molecule 2 Inhibits Pathological Cardiac Hypertrophy by Regulating the MAPK Signaling Pathway},
  journal = {Journal of the American Heart Association},
  year = {2024},
  doi = {10.1161/jaha.124.034257}
}
Kostenlos starten →